DanCann Pharma A/S receives EU-GMP certification for its manufacturing facility Biotech Pharm1
COPENHAGEN, Denmark, 2 December 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announces that the Company will obtain its EU-GMP certification of its facility Biotech Pharm1 (“Biotech Pharm1” or the “Facility”) from the Danish Medicines Agency and subsequently admitted under the Danish Pilot Programme for the manufacturing of cannabis bulk.At DanCann Pharma in Ansager the Danish Medicines Agency has successfully completed their inspection of the Company’s manufacturing Facility with no major deviations. The